HEADER SIGNALING PROTEIN 28-FEB-23 8COJ TITLE CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE CATALYTIC DOMAIN TITLE 2 IN COMPLEX WITH THE INHIBITOR TDI-10228 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AH-RELATED PROTEIN,ADENYLATE CYCLASE HOMOLOG,GERM CELL COMPND 5 SOLUBLE ADENYLYL CYCLASE,SAC,TESTICULAR SOLUBLE ADENYLYL CYCLASE; COMPND 6 EC: 4.6.1.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADCY10, SAC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CAMP, SAC, INHIBITOR COMPLEX, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.STEEGBORN,M.FUSHIMI REVDAT 2 17-MAY-23 8COJ 1 JRNL REVDAT 1 26-APR-23 8COJ 0 JRNL AUTH S.SUN,M.FUSHIMI,T.ROSSETTI,N.KAUR,J.FERREIRA,M.MILLER, JRNL AUTH 2 J.QUAST,J.VAN DEN HEUVEL,C.STEEGBORN,L.R.LEVIN,J.BUCK, JRNL AUTH 3 R.W.MYERS,S.KARGMAN,N.LIVERTON,P.T.MEINKE,D.J.HUGGINS JRNL TITL SCAFFOLD HOPPING AND OPTIMIZATION OF SMALL MOLECULE SOLUBLE JRNL TITL 2 ADENYL CYCLASE INHIBITORS LED BY FREE ENERGY PERTURBATION. JRNL REF J.CHEM.INF.MODEL. V. 63 2828 2023 JRNL REFN ESSN 1549-960X JRNL PMID 37060320 JRNL DOI 10.1021/ACS.JCIM.2C01577 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 32233 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1610 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.4000 - 4.6700 0.99 2810 147 0.1841 0.1825 REMARK 3 2 4.6700 - 3.7100 1.00 2803 148 0.1463 0.1830 REMARK 3 3 3.7100 - 3.2400 1.00 2806 148 0.1727 0.2082 REMARK 3 4 3.2400 - 2.9400 1.00 2785 146 0.2061 0.2207 REMARK 3 5 2.9400 - 2.7300 1.00 2799 148 0.2225 0.2662 REMARK 3 6 2.7300 - 2.5700 1.00 2771 145 0.2332 0.2858 REMARK 3 7 2.5700 - 2.4400 1.00 2795 147 0.2468 0.2796 REMARK 3 8 2.4400 - 2.3400 1.00 2768 146 0.2595 0.2950 REMARK 3 9 2.3400 - 2.2500 1.00 2781 147 0.2814 0.3031 REMARK 3 10 2.2500 - 2.1700 1.00 2771 146 0.3162 0.3369 REMARK 3 11 2.1700 - 2.1000 0.98 2734 142 0.3434 0.3765 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.323 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.900 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 3769 REMARK 3 ANGLE : 0.924 5092 REMARK 3 CHIRALITY : 0.054 560 REMARK 3 PLANARITY : 0.006 649 REMARK 3 DIHEDRAL : 5.928 3060 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 7 THROUGH 108 ) REMARK 3 ORIGIN FOR THE GROUP (A): 8.4303 36.4240 -5.3693 REMARK 3 T TENSOR REMARK 3 T11: 0.2637 T22: 0.2591 REMARK 3 T33: 0.3062 T12: 0.0215 REMARK 3 T13: 0.0279 T23: -0.0192 REMARK 3 L TENSOR REMARK 3 L11: -0.0089 L22: 0.5654 REMARK 3 L33: 0.4372 L12: -0.0652 REMARK 3 L13: 0.2138 L23: -0.1826 REMARK 3 S TENSOR REMARK 3 S11: 0.0046 S12: 0.0816 S13: -0.0057 REMARK 3 S21: -0.0154 S22: -0.0167 S23: -0.0198 REMARK 3 S31: 0.0136 S32: 0.0774 S33: 0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 109 THROUGH 287 ) REMARK 3 ORIGIN FOR THE GROUP (A): 9.9264 30.1310 -12.4570 REMARK 3 T TENSOR REMARK 3 T11: 0.2556 T22: 0.2968 REMARK 3 T33: 0.2714 T12: 0.0387 REMARK 3 T13: 0.0068 T23: -0.0378 REMARK 3 L TENSOR REMARK 3 L11: 0.9068 L22: 1.0464 REMARK 3 L33: 1.5404 L12: -0.3430 REMARK 3 L13: -0.7188 L23: 0.1660 REMARK 3 S TENSOR REMARK 3 S11: -0.0242 S12: -0.0717 S13: -0.0240 REMARK 3 S21: -0.1434 S22: 0.0148 S23: -0.0110 REMARK 3 S31: 0.1772 S32: 0.2113 S33: -0.0002 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 288 THROUGH 468 ) REMARK 3 ORIGIN FOR THE GROUP (A): 13.4191 27.4029 14.5857 REMARK 3 T TENSOR REMARK 3 T11: 0.3287 T22: 0.2367 REMARK 3 T33: 0.2526 T12: 0.0352 REMARK 3 T13: 0.0112 T23: 0.0374 REMARK 3 L TENSOR REMARK 3 L11: 1.0769 L22: 0.6572 REMARK 3 L33: 1.5397 L12: -0.8610 REMARK 3 L13: 0.8911 L23: -0.3321 REMARK 3 S TENSOR REMARK 3 S11: -0.0345 S12: -0.0570 S13: -0.0374 REMARK 3 S21: 0.1517 S22: -0.0217 S23: -0.0026 REMARK 3 S31: 0.0942 S32: 0.1579 S33: 0.0008 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8COJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1292128922. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32292 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 32.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 8.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M TRIPOTASSIUM CITRATE, 20%(W/V) REMARK 280 PEG 3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.87300 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.87300 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.87300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 THR A 3 REMARK 465 PRO A 4 REMARK 465 LYS A 5 REMARK 465 GLU A 6 REMARK 465 THR A 132 REMARK 465 GLN A 133 REMARK 465 GLU A 134 REMARK 465 TRP A 135 REMARK 465 GLU A 136 REMARK 465 GLU A 137 REMARK 465 GLY A 138 REMARK 465 LEU A 139 REMARK 465 VAL A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 51 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 GLU A 353 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 468 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 360 OD1 ASN A 436 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O MET A 237 HZ3 LYS A 443 6554 1.23 REMARK 500 C HIS A 238 HZ1 LYS A 443 6554 1.41 REMARK 500 O MET A 237 NZ LYS A 443 6554 1.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE A 350 CD1 PHE A 350 CE1 -0.237 REMARK 500 PHE A 350 CZ PHE A 350 CE2 -0.302 REMARK 500 PHE A 350 CE2 PHE A 350 CD2 -0.154 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 443 CD - CE - NZ ANGL. DEV. = -14.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 10 34.32 -97.88 REMARK 500 ALA A 97 28.60 -142.35 REMARK 500 ASP A 159 -168.02 -117.42 REMARK 500 ASN A 185 3.86 80.73 REMARK 500 HIS A 238 7.93 -69.21 REMARK 500 TYR A 239 26.66 -141.61 REMARK 500 ASP A 258 89.21 -163.02 REMARK 500 LYS A 340 11.85 59.85 REMARK 500 PRO A 351 -54.88 -27.14 REMARK 500 LYS A 378 -6.99 79.57 REMARK 500 ALA A 454 -172.59 -68.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 49 GLY A 50 -135.63 REMARK 500 PHE A 350 PRO A 351 -143.46 REMARK 500 REMARK 500 REMARK: NULL DBREF 8COJ A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 8COJ HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 8COJ HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 8COJ HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 8COJ HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 8COJ HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 8COJ HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 8COJ CME A 253 CYS MODIFIED RESIDUE HET CME A 253 19 HET VE1 A 501 35 HET DMS A 502 10 HET DMS A 503 10 HET DMS A 504 10 HET DMS A 505 10 HET ACT A 506 7 HET EDO A 507 10 HET EDO A 508 10 HET EDO A 509 10 HET EDO A 510 10 HET EDO A 511 10 HET EDO A 512 10 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM VE1 4-CHLORANYL-6-[4-[(3-FLUOROPHENYL)METHYL]-1-METHYL- HETNAM 2 VE1 PYRAZOL-3-YL]PYRIMIDIN-2-AMINE HETNAM DMS DIMETHYL SULFOXIDE HETNAM ACT ACETATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 VE1 C15 H13 CL F N5 FORMUL 3 DMS 4(C2 H6 O S) FORMUL 7 ACT C2 H3 O2 1- FORMUL 8 EDO 6(C2 H6 O2) FORMUL 14 HOH *120(H2 O) HELIX 1 AA1 TRP A 11 ALA A 18 1 8 HELIX 2 AA2 PRO A 21 TYR A 26 1 6 HELIX 3 AA3 SER A 60 MET A 64 5 5 HELIX 4 AA4 ARG A 66 PHE A 89 1 24 HELIX 5 AA5 GLU A 108 LYS A 110 5 3 HELIX 6 AA6 GLN A 111 LEU A 129 1 19 HELIX 7 AA7 GLY A 169 ALA A 182 1 14 HELIX 8 AA8 SER A 190 CYS A 197 1 8 HELIX 9 AA9 ASN A 225 THR A 235 1 11 HELIX 10 AB1 SER A 242 LYS A 246 5 5 HELIX 11 AB2 ARG A 250 LEU A 255 5 6 HELIX 12 AB3 ASP A 258 LYS A 267 1 10 HELIX 13 AB4 MET A 270 ASP A 278 1 9 HELIX 14 AB5 LYS A 306 GLN A 329 1 24 HELIX 15 AB6 ASP A 357 SER A 374 1 18 HELIX 16 AB7 GLY A 408 TYR A 421 1 14 HELIX 17 AB8 ASP A 428 SER A 435 1 8 HELIX 18 AB9 PRO A 438 TYR A 440 5 3 SHEET 1 AA1 5 ASP A 92 PHE A 96 0 SHEET 2 AA1 5 ALA A 100 ARG A 106 -1 O LEU A 102 N LEU A 94 SHEET 3 AA1 5 PHE A 35 ASP A 47 -1 N MET A 44 O ALA A 103 SHEET 4 AA1 5 LYS A 144 GLY A 158 -1 O ILE A 152 N PHE A 39 SHEET 5 AA1 5 SER A 163 ILE A 168 -1 O ILE A 168 N SER A 153 SHEET 1 AA2 7 ASP A 92 PHE A 96 0 SHEET 2 AA2 7 ALA A 100 ARG A 106 -1 O LEU A 102 N LEU A 94 SHEET 3 AA2 7 PHE A 35 ASP A 47 -1 N MET A 44 O ALA A 103 SHEET 4 AA2 7 LYS A 144 GLY A 158 -1 O ILE A 152 N PHE A 39 SHEET 5 AA2 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AA2 7 GLN A 210 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AA2 7 ILE A 202 VAL A 207 -1 N GLU A 203 O ASN A 216 SHEET 1 AA3 5 GLY A 330 PHE A 338 0 SHEET 2 AA3 5 GLY A 341 PHE A 348 -1 O LEU A 345 N LYS A 334 SHEET 3 AA3 5 GLU A 288 MET A 300 -1 N LEU A 299 O CYS A 342 SHEET 4 AA3 5 THR A 381 HIS A 398 -1 O ALA A 387 N ILE A 294 SHEET 5 AA3 5 ARG A 401 ILE A 407 -1 O ARG A 401 N HIS A 398 SHEET 1 AA4 7 GLY A 330 PHE A 338 0 SHEET 2 AA4 7 GLY A 341 PHE A 348 -1 O LEU A 345 N LYS A 334 SHEET 3 AA4 7 GLU A 288 MET A 300 -1 N LEU A 299 O CYS A 342 SHEET 4 AA4 7 THR A 381 HIS A 398 -1 O ALA A 387 N ILE A 294 SHEET 5 AA4 7 VAL A 425 CYS A 427 1 O THR A 426 N ILE A 384 SHEET 6 AA4 7 TYR A 460 TYR A 462 -1 O TYR A 462 N VAL A 425 SHEET 7 AA4 7 PHE A 442 GLU A 444 -1 N LYS A 443 O GLN A 461 LINK C ALA A 252 N CME A 253 1555 1555 1.33 LINK C CME A 253 N THR A 254 1555 1555 1.32 CISPEP 1 ARG A 33 PRO A 34 0 2.26 CRYST1 98.905 98.905 99.746 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010111 0.005837 0.000000 0.00000 SCALE2 0.000000 0.011675 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010025 0.00000